Document is current
Any future updates will be listed below
-
Authors
Quwaider, Dalia https://orcid.org/0000-0002-0142-0424
Corchete, Luis A.
Martín-Izquierdo, Marta
Hernández-Sánchez, Jesús M.
Rojas, Elizabeta A.
Cardona-Benavides, Ignacio J.
García-Sanz, Ramón
Herrero, Ana B.
Gutiérrez, Norma C.
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PFIS-2020: FI20/00226, PI101076/4, PI19/00674)
Gerencia Regional de Salud, Junta de Castilla y León (GRS 1833/A/18, GRS 2058/A/19)
Asociación Española Contra el Cancer (PROYE20047GUTI3)
Consejería de Educación, Junta de Castilla y León
- License Information
-
More Information
Article History
Received: 1 November 2021
Accepted: 14 March 2022
First Online: 31 March 2022
Declarations
:
: Not applicable.
: Not applicable.
: RGS. Honoraria and travel accommodation: Janssen and Takeda; honoraria: Pharmacyclics; research funding: Hospira; travel accommodation: Celgene; NCG. Honoraria and travel accommodation: Janssen. The other authors declare no conflicts of interest.
